Neogen Corporation (NASDAQ: NEOG) is a leading provider of food safety solutions, offering diagnostic and testing products to ensure the safety and quality of food and animal products. While the company also operates in the animal safety sector, that segment has faced headwinds, including third-party supply chain issues.
On April 9, 2026, Neogen reported fiscal third-quarter 2026 results. Revenue came in at $211.2 million, exceeding the Zacks Consensus Estimate of approximately $204.5 million (a positive surprise of roughly 3.3%). This figure represents a 4.4% decrease compared to $221.0 million in the same period last year.
The company reported a GAAP net loss of $17.0 million, or -$0.08 per diluted share. This missed the consensus GAAP EPS estimate (which had been around breakeven or slightly positive in some forecasts). On an adjusted basis, however, Neogen delivered adjusted net income of $19.4 million and adjusted EPS of $0.09, representing a meaningful beat versus expectations (often cited around $0.06 or lower in preliminary consensus views).
Additional financial highlights include:
CEO Mike Nassif expressed optimism about the company's transformation, particularly the strength in the Food Safety segment. The company is implementing strategic sales initiatives and shifting toward a global, solutions-based selling approach to drive future growth. However, the Animal Safety business continues to face challenges from third-party supply issues, which have impacted overall performance.
